Navigation Links
Alfacell Provides Shareholder Update
Date:6/19/2009

e drug resistance (MDR). A publication regarding this study is in the process of being completed.

To quote Zbigniew Darzynkiewicz, M.D., Ph.D. Professor of Pathology and Medicine; Director, Brander Cancer Research Institute, New York Medical College, a long time collaborator who has published numerous peer reviewed articles regarding the molecular mechanism of Onconase states the following: "We now have compelling evidence from numerous preclinical studies including investigations on animals that Onconase strongly enhances effect of many types of anticancer drugs. The enhancement of the anticancer effectiveness by Onconase was shown to involve prevention of the induction defense mechanism which generally are triggered by the anticancer drugs and provide resistance to treatment. This propensity of Onconase makes it an attractive candidate to be used as an adjunct to variety of cancer treatment protocols. In this capacity Onconase can be widely used in therapy of different tumor types, including most common types such as cancer of breast, prostate, colon, ovary and lung."

Another quote is provided by Harvey I. Pass. Director, New York University Medical Center, Division of Thoracic Surgery; Chief of Thoracic Oncology: "The promising subgroup analysis requested by the FDA exhibiting a significant survival advantage for those individuals previously treated with chemotherapy who received the combination of Onconase and doxorubicin points to molecular mechanisms of inherent or acquired chemotherapy resistance. It is known that there are specific chemotherapy resistance genes which not only are present in untreated mesotheliomas but also become over expressed when certain chemotherapeutic agents, including platinum, are used in the first line therapy of cancer. These genes, known as the multidrug resistance (MDR) gene1 and the multidrug resistance associated protein gene make proteins which act like pumps to keep ch
'/>"/>

SOURCE Alfacell Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alfacell Provides ONCONASE(R) NDA Submission Update
2. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
3. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
4. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
5. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
6. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
7. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
9. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014   TRU-D SmartUVC ... UV disinfection robot, announced today that the General Services ... through November 2019.   This newly formed ... all levels of government purchasers, including Department of Veteran ... as Homeland Security contacts purchasing solutions for the Ebola ...
(Date:12/22/2014)... Inc. (NASDAQ: CYBX ), a global leader in ... announced it will participate in the 33 rd  Annual ... San Francisco . Dan ... at 11:00 AM Pacific Time.  A live audio webcast of ... Relations link on the Cyberonics home page at www.cyberonics.com ...
(Date:12/22/2014)... Maine , Dec. 22, 2014  Mark ... analysis brief providing a summary of the 2015 ... plan enrollment trends.  According to ... for Planning and Evaluation, Department of Health and ... were enrolled in individual medical plans through the ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Insights into the Marketplace and Individual Market Growth 2
... Inc. (NYSE: SMA ), a leading global ... surgical instruments, and sterilization cases and trays, announced today ... Olsen Medical. Olsen Medical is a privately-held, ... electrosurgical instruments and accessories. It manufactures a full line ...
... LOVELAND, Colo., Aug. 18, 2011 ... the "Company"), a provider of advanced veterinary diagnostic and ... retained Hayden IR, a national, New York-based investor relations ... raise its visibility and strengthen its relationships with the ...
Cached Medicine Technology:Symmetry Medical Closes Olsen Medical Acquisition 2Heska Retains Hayden IR to Develop Comprehensive Investor Relations Program 2Heska Retains Hayden IR to Develop Comprehensive Investor Relations Program 3
(Date:12/22/2014)... and state health officials are investigating a listeria outbreak ... four people and sickened 28 others in 10 states. ... caramel apples until more information becomes available, the U.S. ... news release. As of Dec. 18, a total ... strains of the bacteria Listeria monocytogenes . Of ...
(Date:12/22/2014)... 2014 Super Saturday, the last Saturday ... as the busiest day in the 2014 holiday shopping ... Station had a steady pre-Christmas stream of customers, ready ... Saturday. , “I definitely intend to take advantage…of the ... resident who was enjoying The Grass Station’s holiday sale ...
(Date:12/22/2014)... 22, 2014 In recognition of Veteran’s ... to Hero Reward, a local organization that provides services ... , Located on a couple hundred acres in ... offers lodging, world class fishing, hunting, hiking, horseback riding, ... founded several years ago to support U.S. Service men ...
(Date:12/22/2014)... December 22, 2014 7,178 small business ... of Black Friday shopping and opted instead to join ... education company, for their 5th annual “Black Friday Boot ... just $7 to attend the 5 hour online training ... promptly donated to support two Central Texas based charities ...
(Date:12/22/2014)... 2014 NAPW honors ... of the Year. Ms. Foley is recognized with this ... most-recognized networking organization of professional women in the country, ... of Professional Women is a powerfully vibrant networking community ... , “As a nurse, I felt like I made ...
Breaking Medicine News(10 mins):Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 2Health News:Austin Company Digital Marketer Raises 100K to Fight Childhood Cancer 3Health News:National Association of Professional Women Announces Michelle M. Foley, Vice President of Operations of OTTR Chronic Care Solutions, a 2014 Professional Woman of the Year 2
... ... Americans affected by infertility, RESOLVE: The National Infertility Association and Fertility LifeLines™, a free ... Film Competition. , ... (PRWEB) July 6, 2009 -- Lights, camera, action! To provide support and hope to ...
... (NYSE: CSC ) today announced that it will kick ... with the American Red Cross at CSC,s new global headquarters in ... marks the first in a series of blood drives toward meeting ... Chairman, President and Chief Executive Officer Michael W. Laphen; James W. ...
... 6 MasterCard Worldwide today announced a multi-year contract ... Bank to issue MasterCard cards for health savings accounts ... (HRAs), including the accounts they manage for UnitedHealthcare members. ... of payment, tied to these tax-advantaged accounts, for eligible ...
... (Amex: NBS ), which is pioneering the ... cells for future medical need, announced today it has ... the Company,s Vice President of Drug Development and Regulatory ... position will be overseeing NeoStem,s therapeutic development activities and ...
... July 6 Coapt Systems, Inc. ( www.coaptsystems.com ... FDA-approved hyaluronic acid based dermal filler for the treatment ... "smile lines." Hydrelle is the first FDA-approved hyaluronic ... patient comfort. Proven safe and effective, Hydrelle is ...
... ... dentistry,s responsibility in the recognition and management of snoring and sleep apnea, announces the launch ... ... LLC, the web,s fastest growing source of information on dentistry,s responsibility in the recognition and ...
Cached Medicine News:Health News:Calling All Aspiring Filmmakers! The In The Know Short Film Competition Announces Call for Entries Women and Couples Encouraged to Enter TODAY, Share Their Fertility Stories and Inspire Others 2Health News:Calling All Aspiring Filmmakers! The In The Know Short Film Competition Announces Call for Entries Women and Couples Encouraged to Enter TODAY, Share Their Fertility Stories and Inspire Others 3Health News:CSC to Kick Off National Blood Drive Campaign July 8 at Global Headquarters in Virginia 2Health News:MasterCard Extends Agreement With OptumHealth 2Health News:MasterCard Extends Agreement With OptumHealth 3Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 2Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 3Health News:NeoStem, Inc. Appoints International Expert in Endocrinology and Pharmacology as Vice President of Drug Development and Regulatory Affairs 4Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 2Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 3Health News:Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort 4Health News:Snoring Isn't Sexy, LLC Launches Discussion Forum for the Public 2
... RELISA ENA Multiparameter Kit is ... for six of the most ... a unique quality control system. ... Check) well in each strip ...
... RELISA ENA assays were designed with the ... clinician in the diagnosis of autoimmune disease. ... disease and 1,000 normal individuals were tested ... Test System. Immuno Concepts compared the results ...
... functional human C1q coated in the solid phase ... stage, CIC in the diluted patient samples and ... into the C1q coated assay wells. After incubation, ... and a ready to use conjugate (goat anti-human ...
... CIC are formed as a host ... cleared by phagocytosis. If not cleared, CIC ... inflammatory response. CIC are increased in Systemic ... may be involved in other autoimmune disorders ...
Medicine Products: